Interestingly, when we analyzed insulin signaling through Akt phosphorylation, we observed that PIO treatment was not able to reverse insulin signaling in the artery of mice with obesity (Figures 5D, E), even though it clearly improved whole-body insulin sensitivity. This evidence concerns the gene AKT1 and obesity due to melanocortin 4 receptor deficiency.